Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/4204
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSly, P. D.en
dc.contributor.authorWainwright, Claireen
dc.date.accessioned2022-11-07T23:50:26Z-
dc.date.available2022-11-07T23:50:26Z-
dc.date.issued2017en
dc.identifier.citation14, (6), 2017, p. 833-835en
dc.identifier.otherRISen
dc.identifier.urihttp://dora.health.qld.gov.au/qldresearchjspui/handle/1/4204-
dc.description.abstractL6166276852017-06-09 <br />2017-06-14 <br />en
dc.language.isoenen
dc.relation.ispartofAnnals of the American Thoracic Societyen
dc.titlePreserving lung function: The holy grail in managing cystic fibrosisen
dc.typeArticleen
dc.identifier.doi10.1513/AnnalsATS.201703-254EDen
dc.subject.keywordsregisteren
dc.subject.keywordsreviewen
dc.subject.keywordsspirometryen
dc.subject.keywordssurvivalen
dc.subject.keywordslung clearanceen
dc.subject.keywordshumanen
dc.subject.keywordslung functionen
dc.subject.keywordsforced expirationen
dc.subject.keywordscystic fibrosisen
dc.subject.keywordsantibiotic therapyen
dc.subject.keywordsantibiotic agentquinoloneen
dc.subject.keywordsforced expiratory volumeen
dc.subject.keywordslung function testen
dc.relation.urlhttps://www.embase.com/search/results?subaction=viewrecord&id=L616627685&from=exporthttp://dx.doi.org/10.1513/AnnalsATS.201703-254ED |en
dc.identifier.risid1568en
dc.description.pages833-835en
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairetypeArticle-
Appears in Sites:Children's Health Queensland Publications
Show simple item record

Page view(s)

60
checked on Feb 14, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.